TranS1, Inc. Completes $94 Million IPO
Represented TranS1, a provider of medical devices to treat degenerative disc disease and instability affecting the spine, in its 2007 $94 million IPO.
Related Attorneys
Represented TranS1, a provider of medical devices to treat degenerative disc disease and instability affecting the spine, in its 2007 $94 million IPO.
